Clinical Trial Update: Evaluation of Adjuvant Hormonal Treatment for 24 Months After Radical Prostatectomy in High Risk of Recurrence Patients. [Phase 3]

View source ↗

Summary

This update covers a Phase 3 trial evaluating 24 months of adjuvant hormonal therapy after radical prostatectomy in high-risk prostate cancer patients. The tria…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Adjuvant hormonal therapy

Snippet

Sponsor: UNICANCER | Conditions: Metastases | Phase 3 | Status: ACTIVE_NOT_RECRUITING